Abstract
Parkinson's disease (PD) is the second most common neurodegenerative disease in the world, generating progressive debilitations to the patient, such as motor impairment, cognitive and psychiatric deficits. Of all registered cases of the disease, only 10% are familial whereas 90% of them are of unknown causes, that is, idiopathic (iPD). Despite intensive research, attempts to stop or even …